Geneva University Hospitals
Geneva, 1205, Switzerland
Location status: Recruiting
Location contact
Jennifer Villers, PhD
CONTACT
Virginie Prendki, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06998251
The NoseSpn-Elderly study aims at characterizing the immune response in the upper respiratory tract in adults aged 60 and over diagnosed with a pneumonia due to a Streptococcus pneumoniae (Spn) infection. The immune response during the acute phase of the infection and after recovery will be compared to the immune response of asymptomatic Spn carriers as well as to the immune response of patients diagnosed with a viral respiratory infection (flu or respiratory syncytial virus (RSV)).
The primary objective of this observational study is to quantify the inflammatory response in the nasal cavity and to correlate it with bacterial/viral load and with clinical parameters. The study also aims to compare the inflammatory response measured in the nose to that measured in the blood.
Participants will have two study visits including a blood draw, several nasal samplings (nasal lining fluid and nasal cells) and a saliva sampling, one within 72 hours of their hospital admission and another one month later. Nasal lining fluid and saliva will be obtained every two or three days until discharge from the hospital or resolution of symptoms. During those visits, questions regarding symptoms will be asked.
Interested in participating?
Request Info60 year–85 year
All sexes
Observational
Geneva, 1205, Switzerland
Location status: Recruiting
Jennifer Villers, PhD
CONTACT
Virginie Prendki, MD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 month
Time frame: 1 month
Time frame: 1 month
Time frame: 1 month
Time frame: 1 month
Time frame: 1 month
Probability of diagnosis of pneumonia (on a 3-Likert scale: low, intermediate and high level of probability)
Time frame: 1 month
Time frame: 1 month
Time frame: 1 month
Time frame: 1 month
Time frame: 1 month
Time frame: 1 month
Time frame: 1 month
Only for group 2 patients (viral infection)
Time frame: 1 month
Time frame: 1 month
Time frame: 1 month
Time frame: 1 month
Time frame: 1 month
Time frame: 1 month
Time frame: 1 month
Time frame: 1 month
Contact information is provided by the study sponsor or research team.
University Hospital, Geneva
Other
Acronym: NoseSpnElderly
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06822907
Acute Febrile Illness, Bacterial Infections
Saint-Etienne, France
View Trial DetailsNCT05412030
Bacterial Infections, Bacterial Infections and Mycoses
Jonesboro, Arkansas, United States
View Trial DetailsNCT04664556
Antibiotic Treatment, Bacterial Infections
Créteil, France
View Trial DetailsNCT07017777
Bacterial Infections, Bacterial Infections and Mycoses
Bangkok, Thailand
View Trial Details